相关实验视频
Updated: Jul 18, 2025

03:57
Electrochemotherapy of Tumours
Published on: December 15, 2008
24.6K
在固体腹部器官和骨瘤中进行电化学疗法的最佳剂量和患者选择
Cora H Martin1, Robert C G Martin1
1Division of Surgical Oncology, Department of Surgery, University of Louisville School of Medicine, Louisville, KY 40202, USA.
Bioengineering (Basel, Switzerland)
|August 26, 2023
概括
电化学疗法 (ECT) 对深部固体器官瘤有希望. 优化患者选择,瘤学标准和像Clinporator这样的技术可以提高治疗响应率.
科学领域:
- 在瘤学瘤学.
- 医疗技术 医疗技术 医学技术
- 临床研究 临床研究
背景情况:
- 固体器官中的深部瘤会带来治疗挑战.
- 电化学疗法 (ECT) 是局部癌症治疗的一种新兴方式.
- 关于优化ECT对内脏和骨转移的数据有限.
研究的目的:
- 分析关于电化学疗法 (ECT) 对深部固体器官瘤的研究.
- 确定患者选择,瘤学标准和技术使用的关键因素.
- 评估响应率并优化对内脏和骨损伤的ECT协议.
主要方法:
- 2017-2023年对电化学疗法 (ECT) 研究的系统文献综述.
- 包括/排除标准适用于29个选定的出版物.
- 分析患者的特征,瘤病史和技术 (ClinporatorTM,SOPs).
主要成果:
- 关键的患者选择因素:白素的适用性,>3个月的预期寿命,不可切除的病变,晚期癌症.
- 瘤选择:通常用于化学疗法/手术后复发性疾病.
- 技术:ClinporatorTM和更新的标准操作程序与更好的响应率相关.
结论:
- 优化患者和瘤选择对于成功的ECT至关重要.
- 先进的技术和标准化的协议提高了 ECT 在固体器官瘤中的疗效.
- ECT为耐火性深层固体器官恶性瘤提供了一种可行的治疗选择.
相关概念视频
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K

